Cytosorbents Corporation (CTSO): Price and Financial Metrics
Cytosorbents Corporation (CTSO)
Today's Latest Price: $8.36 USD
Updated Nov 27 1:00pm
Add CTSO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
CTSO Stock Summary
- With a price/sales ratio of 9.89, Cytosorbents Corp has a higher such ratio than 85.06% of stocks in our set.
- As for revenue growth, note that CTSO's revenue has grown 54.57% over the past 12 months; that beats the revenue growth of 90.55% of US companies in our set.
- Cytosorbents Corp's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -22.77%, greater than the shareholder yield of only 14.06% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to Cytosorbents Corp, a group of peers worth examining would be FLDM, TWOU, LEAF, MBII, and OBLN.
- CTSO's SEC filings can be seen here. And to visit Cytosorbents Corp's official web site, go to www.cytosorbents.com.
CTSO Stock Price Chart Interactive Chart >
CTSO Price/Volume Stats
| Current price | $8.36 | 52-week high | $11.74 |
| Prev. close | $8.19 | 52-week low | $3.49 |
| Day low | $8.21 | Volume | 145,400 |
| Day high | $8.48 | Avg. volume | 576,589 |
| 50-day MA | $8.31 | Dividend yield | N/A |
| 200-day MA | $8.37 | Market Cap | 360.95M |
Cytosorbents Corporation (CTSO) Company Bio
CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer technology. The company was founded in 1997 and is based in Monmouth Junction, New Jersey.
Loading social stream, please wait...